This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Analysts' Actions: AZO, BMY, LLY, MS

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Autozone (AZO - Get Report) was upgraded at Credit Suisse to Outperform. Valuation call, based on a $440 price target, Credit Suisse said.

Bristol-Myers (BMY - Get Report) was initiated with an Outperform rating at BMO Capital. $39 price target. Company's growth potential is underestimated by the market, BMO Capital said.

Cavium (CAVM) was downgraded at UBS to Neutral from Buy. $26 price target. Macro raises risks to growth, UBS said.

Canadian Pacific (CP) was upgraded at Citigroup to Buy from Neutral. $90 price target. Proxy battle ends, turnaround begins, Citi said.

Cypress (CY) was downgraded at UBS to Neutral from Buy. $13.75 price target. Less conviction on cycle strength and operating margins, UBS said.

Gamestop (GME) was downgraded at Caris & Company from Buy to Average. $20 price target. Company is seeing lower store traffic, Caris & Company said.

Hub Group (HUBG) was upgraded at Stifel Nicolaus from Hold to Buy. Valuation call, based on a $41 price target, Stifel Nicolaus said.

Kansas City Southern (KSU) was upgraded at BMO Capital from Underperform to Neutral. Valuation call, as the stock is down 16% over the past two weeks, BMO Capital said. $68 price target.

Eli Lilly (LLY - Get Report) was rated new Market Perform at BMO Capital. $37 price target. Company is facing multiple patent expiration cliffs, BMO Capital said.

Merck (MRK - Get Report) was initiated with a Market Perform rating at BMO Capital. Valuation call, based on a $43 price target.

Morgan Stanley (MS - Get Report) was upgraded at UBS to Buy from Neutral. $19 price target. Much of the downside seems priced in, with plenty of leverage to the upside, UBS said.

Petrobras (PBR) was upgraded at Societe Generale to Buy from Neutral. $25 price target. Stock is attractively valued, following a 38% decline, Societe Generale said.

Pepco Holdings (POM) was initiated with a Neutral rating at Citigroup. $19 price target. Overhang from several rate case proceedings, Citigroup said.

Phillips 66 (PSX) was initiated with a Buy rating at UBS. $37 price target. Embedded logistics valuation at forefront, UBS said.

Bankrate (RATE) was downgraded at Goldman Sachs from Buy to Neutral. Valuation call, based on a $25 price target, Goldman Sachs said.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
BMY $66.35 0.45%
AZO $650.97 0.00%
LLY $70.59 0.00%
MS $35.52 0.00%
MRK $57.98 0.00%

Markets

DOW 18,135.72 +38.82 0.21%
S&P 500 2,101.04 +2.51 0.12%
NASDAQ 4,982.8090 +15.6680 0.32%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs